CJ-042794

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H17ClFNO4
Molecular Weight	413.826
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](NC(=O)C1=CC(Cl)=CC=C1OC2=CC=C(F)C=C2)C3=CC=C(C=C3)C(O)=O

InChI

InChIKey=MWBNCZHVEXULBD-ZDUSSCGKSA-N

InChI=1S/C22H17ClFNO4/c1-13(14-2-4-15(5-3-14)22(27)28)25-21(26)19-12-16(23)6-11-20(19)29-18-9-7-17(24)8-10-18/h2-13H,1H3,(H,25,26)(H,27,28)/t13-/m0/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Prostanoid EP4 receptor 11 Target ID: CHEMBL1836 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18155068 \| https://www.ncbi.nlm.nih.gov/pubmed/17578900	Antagonist 2778

PubMed

Title	Date	PubMed

Name

Type

Language

CJ-042794

Code

English

Benzoic acid, 4-[(1S)-1-[[5-chloro-2-(4-fluorophenoxy)benzoyl]amino]ethyl]-

Systematic Name

English

4-((1R)-1-((5-CHLORANYL-2-(4-FLUORANYLPHENOXY)PHENYL)CARBONYLAMINO)ETHYL)BENZOIC ACID

Systematic Name

English

Code System Code Type Description

FDA UNII

CN7Z4P7QXS

Created by admin on Sat Dec 16 16:14:26 GMT 2023 , Edited by admin on Sat Dec 16 16:14:26 GMT 2023

PRIMARY

PUBCHEM

11524454

Created by admin on Sat Dec 16 16:14:26 GMT 2023 , Edited by admin on Sat Dec 16 16:14:26 GMT 2023

PRIMARY

CAS

847728-01-2

Created by admin on Sat Dec 16 16:14:26 GMT 2023 , Edited by admin on Sat Dec 16 16:14:26 GMT 2023

PRIMARY

EPA CompTox

DTXSID60468041

Created by admin on Sat Dec 16 16:14:26 GMT 2023 , Edited by admin on Sat Dec 16 16:14:26 GMT 2023

PRIMARY

ACTIVE MOIETY


					CN7Z4P7QXS

CJ-042794